Company profile
- Industry
- Pharmacy retail
- Founded
- 1901
- Headquarters
- Deerfield, United States
- Ownership
- Subsidiary of Walgreens Boots Alliance, Inc.
Profiles are auto-generated and infrequently updated.
Decisions on record
3 verified Decision Records on Walgreens, and the casebook each one belongs to.
| Fork date | Decision type | The story | Casebook |
|---|---|---|---|
| 2020 | The Counterfactual | Read the story → | The Counterfactual Casebook → |
| 2021 | Adjacency Expansion | Read the story → | Adjacency Expansion Casebook → |
| 2025 | The Fall | Read the story → | The Fall Casebook → |
Run one of these yourself
The decisions Walgreens faced, as kits you can run.
Each pack takes one of these decisions and gives you the framework, a deck for the room, a model that resolves to one number, and the sourced cases behind it. $499, one-time.
Growth & PortfolioThe Adjacency ExpansionWhen does the business next door belong to you?See the pack →Decision ForksThe Road Not TakenWhat did the decision you did not take actually cost?See the pack →Decision ForksThe ResidualHow much of your decline can the agreed explanation actually account for?See the pack →
The analyses
The Adjacency Expansion · Growth & Portfolio
Walgreens Spent $12 Billion Buying Its Way Into Healthcare. It Bought a Trap.
Walgreens poured nearly $12B into VillageMD primary care in five escalating steps. Each one deepened the bet before the last one paid off—until a $12.369B goodwill write-down in 2024 proved the adjacency was right and the financing was fatal.
8 min
The Counterfactual · Decision Forks
Walgreens Lost to CVS in a Boardroom, Not a Store Aisle
Walgreens kept more foot traffic than CVS right up to the end - 50% of the two chains' visits. It still got taken private in a roughly $10 billion fire sale. The reason wasn't worse stores. It was one capital-allocation bet that went 13x bigger at CVS.
8 min
The Fall · Crisis & Reinvention
Walgreens Wrote Down $12.4 Billion on an Unproven Healthcare Bet and Was Carved Into Five Pieces
A former Dow component went private and was carved into five pieces on a single August day in 2025. The story isn't a corner-drugstore failing. It's a $12.4 billion goodwill write-down on a healthcare bet that was never commercially proven.
8 min
The Fall · Crisis & Reinvention
Walgreens Went Private at $11.45 a Share, Dead of Three Wounds It Had the Data to Avoid
In March 2025 Walgreens agreed to go private at $11.45 a share — roughly 83% below its 2015 peak of approximately $66 a share. This wasn't a rescue. It was a liquidation, and the autopsy shows three self-inflicted wounds management had the data to avoid.
8 min